Because HGK deletion in T cells leads to the development of T2D in mice [17], we studied whether HGK levels are decreased in peripheral blood T cells of human T2D patients using clinical samples from drug-naïve, impaired-glucose-tolerance (IGT; a pre-diabetic state) and T2D patients, along with samples from healthy controls (Supplementary Table S1 and Supplementary Figure S1). Here, MAP4K4 is linked to Impaired glucose tolerance.